Wedbush Downgrades XOMA, Ltd. (XOMA) to Neutral

November 14, 2016 6:23 AM EST
Get Alerts XOMA Hot Sheet
Price: $4.44 --0%

Rating Summary:
    3 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 11 | New: 7
Trade XOMA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Wedbush downgraded XOMA, Ltd. (NASDAQ: XOMA) from Outperform to Neutral with a price target of $14.00 (from $17.00), citing near-term financing overhang.

Analyst Liana Moussatos commented, "Despite positive early clinical results for XOMA 358 in congenital hyperinsulinism (CHI) and an anticipated $10 million milestone payment and potential for other non-dilutive funding in the coming months, we are downgrading to NEUTRAL in front of an anticipated dilutive financing before cash runway runs out in Q2 2017. The anticipated dilution also reduced our price target."

For an analyst ratings summary and ratings history on XOMA, Ltd. click here. For more ratings news on XOMA, Ltd. click here.

Shares of XOMA, Ltd. closed at $6.58 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades

Related Entities

Liana Moussatos

Add Your Comment